Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $193.00
Axsome Therapeutics (NASDAQ:AXSM – Free Report) had its price target boosted by Royal Bank of Canada from $190.00 to $193.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has an outperform rating on the stock. AXSM has been the topic of a number of other reports. Bank of America boosted their price objective […]
Axsome Therapeutics (NASDAQ:AXSM – Free Report) had its price target boosted by Royal Bank of Canada from $190.00 to $193.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has an outperform rating on the stock. AXSM has been the topic of a number of other reports. Bank of America boosted their price objective […]
